Quince Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · SOUTH SAN FRANCISCO
Moderate confidence (50%)
Updated Oct 16, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Quince Therapeutics, Inc. received a delisting notice from its exchange (Aug 31, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Quince Therapeutics, Inc. received a delisting notice from its exchange
Aug 31, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 31, 2026, Quince Therapeutics, Inc. (the Company ) received a written notification ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the Company s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, the Company s stockholders equity was ($35,324,000), and therefore, the Company was not in compliance with Nasdaq Listing Rule 5450(b)(1)(A), which requires a $10,000,000 minimum sto…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Biological Products, (No Diagnostic Substances)
- Subindustry
- —
- Listing
- SEC lists the ticker QNCX on Nasdaq.
- SEC CIK
- 0001662774
- Website
- —
- —
- Headquarters
- SOUTH SAN FRANCISCO
- Also known as
- Cortexyme, Inc.
- Legal entities
- Quince Therapeutics, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Quince Therapeutics, Inc. — Biological Products, (No Diagnostic Substances) (SIC 2836) — SOUTH SAN FRANCISCO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 31, 2026, Quince Therapeutics, Inc. (the Company ) received a written notification ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the Company s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, the Company s stockholders equity was ($35,324,000), and therefore, the Company was not in compliance with Nasdaq Listing Rule 5450(b)(1)(A), which requires a $10,000,000 minimum sto…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 02:39 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.